title: Deus ex Makena?
authors.affiliation: Dr. Silver is from the University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, Utah; e-mail: bob.silver@hsc.utah.edu. Dr. Cunningham is from the University of Texas Southwestern Medical Center at Dallas, Department of Obstetrics and Gynecology, Dallas, Texas; e-mail: gary.cunningham@utsouthwestern.edu.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Silver
authors.forename: F Gary
authors.initials: FG
authors.lastname: Cunningham
mesh_terms: D000077713:17 alpha-Hydroxyprogesterone Caproate; D000282:Administration, Intravaginal; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000191:economics* / Q000627:therapeutic use; D011247:Pregnancy; D047928:Premature Birth / Q000517:prevention & control*; D011374:Progesterone / Q000008:administration & dosage*; D011372:Progestins / Q000008:administration & dosage*
chemical_list: D006908:Hydroxyprogesterones; D011372:Progestins; D000077713:17 alpha-Hydroxyprogesterone Caproate; D011374:Progesterone